Progressive Care Announces Third Quarter Conference Call and
Webcast with Investors on November 21, 2016
MIAMI, FL -- November 11, 2016 -- InvestorsHub NewsWire --
Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary
Pharmco LLC, a South Florida health services organization and
provider of prescription pharmaceuticals specializing in health
practice risk management, compounded medications, the sale of
anti-retroviral medications and related medication therapy
management, and the supply of prescription medications to long term
care facilities, announced today that it will host its Third
Quarter 2016 financial results conference call on Monday, November
21, 2016 at 9:00 AM Eastern Time. Our management team will comment
on Progressive Cares financial and operational results for third
quarter ended September 30, 2016.
The Company has requested a filing deadline extension with OTC
Markets. The Company is taking extra measures outside of its normal
accounting procedures to ensure that the convertibility features of
the Chicago Venture Note issued in the third quarter are properly
valuated and comply with the highest possible financial reporting
standards.
The Company is committed to achieving the goal of auditing our
financial statements for fiscal year 2016, stated S. Parikh Mars,
CEO. To this end, extra steps are being taken to use the most
appropriate valuation model for the convertible note issued in the
third quarter.
We encourage participants to pre-register for the conference
call using the following link.
http://dpregister.com/10096627
Callers who pre-register will be given a conference passcode and
unique PIN to gain immediate access to the call and bypass the live
operator. A calendar reminder will be sent providing easy access on
the day of the conference. Participants may pre-register at any
time, including up to and after the call start time.
A live webcast will be available via the investor relations
section of our website.
About Progressive Care
Progressive Care, Inc. (OTC PINK: RXMD), through its subsidiary
PharmCo, LLC, is a South Florida health services organization and
provider of prescription pharmaceuticals specializing in health
practice risk management, compounded medications, the sale of
anti-retroviral medications and related medication therapy
management, and the supply of prescription medications to long term
care facilities.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or
historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Companys
expectations about its future operating results, performance and
opportunities that involve substantial risks and uncertainties.
These statements include but are not limited to statements
regarding the intended terms of the offering, closing of the
offering and use of any proceeds from the offering. When used
herein, the words anticipate, believe, estimate, upcoming, plan,
target, intend and expect and similar expressions, as they relate
to Progressive Care Inc., its subsidiaries, or its management, are
intended to identify such forward-looking statements. These
forward-looking statements are based on information currently
available to the Company and are subject to a number of risks,
uncertainties, and other factors that could cause the Company's
actual results, performance, prospects, and opportunities to differ
materially from those expressed in, or implied by, these
forward-looking statements.
Contact
Armen Karapetyan
Senior Advisor Business Development
armen@progressivecareus.com